ENTOS PHARMACEUTICALS INC has a total of 14 patent applications. It decreased the IP activity by 28.0%. Its first patent ever was published in 2016. It filed its patents most often in Canada, United States and Australia. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are TECON BIOLOGICAL CO LTD, INT AIDS VACCINE INITIATIVE and BIOPOA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | United States | 3 | |
#3 | Australia | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | China | 1 | |
#7 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Lewis John | 8 |
#2 | Stoletov Konstantin | 7 |
#3 | Willetts Lian | 7 |
#4 | Duncan Roy | 6 |
#5 | Pan Chungen | 5 |
#6 | De Antueno Roberto Justo | 1 |
#7 | Lian Willetts | 1 |
#8 | Clancy Eileen Kathryn | 1 |
#9 | John Lewis | 1 |
#10 | Konstantin Stoletov | 1 |
Publication | Filing date | Title |
---|---|---|
US2019367566A1 | Recombinant Polypepties for Membrane Fusion and Uses Thereof | |
AU2018288571A1 | Recombinant oncolytic viruses for treatment of metastatic cancers | |
CA2932910A1 | Methods for diagnosing and treating metastatic cancer |